4-amino-N-((4S,5S)-1-azabicyclo[3.3.1]nonan-4-yl)-5-chloro-2-methoxybenzamide-13CD3
Dalotutumab (Renzapride)-13C-d3 is a fully characterized chemical compound used as a reference standard of API Dalotutumab. The standard offered is compliant with regulatory guidelines. Dalotutumab (Renzapride)-13C-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -